0001209191-18-020470.txt : 20180319 0001209191-18-020470.hdr.sgml : 20180319 20180319094410 ACCESSION NUMBER: 0001209191-18-020470 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180319 DATE AS OF CHANGE: 20180319 EFFECTIVENESS DATE: 20180319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307993 FILM NUMBER: 18697671 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 D 1 primary_doc.xml X0708 D LIVE 0000707511 REGENERX BIOPHARMACEUTICALS INC 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 301-208-9191 DELAWARE Alpha One Biomedicals, Inc ALPHA 1 BIOMEDICALS INC Corporation true J.J. Finkelstein 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Executive Officer Allan L. Goldstein 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director Mauro Bove 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director R. Don Elsey 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director Joseph McNay 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director Pharmaceuticals Decline to Disclose 06b false 2018-03-02 false true true true false 0 Maxim Group, LLC 120708 Maxim Group LLC 120708 405 Lexington Avenue New York NY NEW YORK 10174 All States 888253 888253 0 Total offering amount and total amount sold include warrants to purchase 3,860,294 shares of common stock false 2 61764 0 In addition, the selling agent received warrants to purchase 102,941 shares of common stock 0 false REGENERX BIOPHARMACEUTICALS INC /s/ J.J. Finkelstein J.J. Finkelstein Chief Executive Officer 2018-03-13